FDA Inspection
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)FDA Inspection 982472 - Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) - July 15, 2016
Record Details
This FDA Inspection record concerns Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site), with an inspection on July 15, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 15, 2016
- Product Type
- Drugs
View Company Profile
ID · 300812ca-aad1-4acb-9cdd-f366eeabee9b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 982472
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 21, 2023 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 14, 2010 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 21, 2008 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)
- FDA Inspection 1218824 - 2023-09-21
- FDA Inspection 865961 - 2013-12-13
- FDA Inspection 697592 - 2010-10-14
- FDA Inspection 552585 - 2008-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.